Clinical trial · Observational
HPV in Adolescents
Prevalence of HPV and Intraepithelial Neoplasia Biomarkers in Adolescents
NCT01788852CI-TRIAL-00017354completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will assess the prevalence of HPV infection in perinatally HIV-infected adolescents, intraepithelial neoplasia, and E6E7 biomarker at cervical and anal sites.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical/Anal Dysplasia | — | UNRESOLVED | — |
| HPV Infection | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- Perinatally HIV-infected adolescents
- description
- Perinatally HIV-infected adolescents
- label
- behaviorally HIV-infected adolescents
- description
- behaviorally HIV-infected adolescents
- label
- HIV negative adolescents
- description
- HIV negative adolescents
Primary outcomes (1)
- measure
- HPV infection
- timeFrame
- 48 weeks
- description
- Prevalence of cervical and anal HPV infection and of oncogenic subtypes, among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents, and HIv-negative adolescents
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
- Maximum age
- 24 Years
Show eligibility criteria text
Inclusion Criteria: * Perinatally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid testing (NAT) at any time and history of maternal HIV infection) * behaviorally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid testing (NAT) at any time after sexual debut without history of maternal HIV infection) * female with vaginal or receptive anal intercourse with a male OR male with receptive rectal intercourse with another male * Signed informed consent. Volunteers aged 12-17 years can decide whether they wish for their parents to consent for their participation. Due to the confidential nature of the issues being studied, parental consent may be exempted Exclusion Criteria: * Have any conditions that may interfer with subjects' ability to understand and consent to the study
References
Publications (0)
Data not yet available
No reference posted for this study.